{"id":"metformin-and-insulin","safety":{"commonSideEffects":[{"rate":"variable, depends on insulin dose","effect":"Hypoglycemia"},{"rate":"10-30","effect":"Gastrointestinal disturbance (metformin component)"},{"rate":"variable","effect":"Weight gain"},{"rate":"1-5","effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that decreases gluconeogenesis and glycogenolysis in the liver and increases peripheral glucose uptake and utilization. Insulin is a hormone that facilitates glucose uptake into cells and promotes anabolic metabolism. The combination addresses both insulin resistance (metformin) and absolute or relative insulin deficiency (insulin) in diabetes management.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while insulin directly replaces or supplements endogenous insulin to lower blood glucose.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:37.767Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT04128995","phase":"PHASE4","title":"Surgical or Medical Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-12-15","conditions":"Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate","enrollment":88},{"nctId":"NCT00445627","phase":"","title":"Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-06-18","conditions":"Obesity, Overweight, Diabetes Mellitus, Type 2","enrollment":82},{"nctId":"NCT07460336","phase":"NA","title":"Effects of Cofrogliptin on Beta-Cell Function in LADA Patients","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-03-15","conditions":"Latent Autoimmune Diabetes in Adults (LADA)","enrollment":84},{"nctId":"NCT07120828","phase":"PHASE4","title":"The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity","status":"COMPLETED","sponsor":"Erbil Polytechnic University","startDate":"2025-07-15","conditions":"Type 2 Diabetes, Obese Diabetics, Obese Patients (BMI ≥ 30 kg/m²)","enrollment":260},{"nctId":"NCT07472179","phase":"NA","title":"Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS","status":"COMPLETED","sponsor":"Mst.Sumyara Khatun","startDate":"2024-08-12","conditions":"PCOS(Insulin Resistant)","enrollment":60},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07452913","phase":"PHASE4","title":"Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Bahria University","startDate":"2026-01-01","conditions":"Type 2 Diabetes Mellitus","enrollment":110},{"nctId":"NCT05042505","phase":"NA","title":"Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation","status":"COMPLETED","sponsor":"Medanta, The Medicity, India","startDate":"2022-01-01","conditions":"Diabetes Mellitus, Liver Transplant; Complications","enrollment":100},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT03905941","phase":"EARLY_PHASE1","title":"Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-08-23","conditions":"Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT02616666","phase":"PHASE4","title":"A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2016-08-25","conditions":"Type 2 Diabetes Mellitus","enrollment":632},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":"Heart Failure, Diabetes","enrollment":1100},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT07415226","phase":"","title":"Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-05-01","conditions":"Type 1 Diabetes Mellitus","enrollment":500},{"nctId":"NCT07173712","phase":"PHASE4","title":"Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Yanbing Li","startDate":"2026-03-15","conditions":"Type 2 Diabetes","enrollment":324},{"nctId":"NCT07380841","phase":"NA","title":"Metformin vs Inositol vs Diet vs Combination Therapy in PCOS","status":"COMPLETED","sponsor":"Islamabad Medical and Dental College","startDate":"2025-05-21","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Metabolic Syndrome","enrollment":192},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":"Heart Failure, Diabete Type 2, Arterial Hypertension","enrollment":120},{"nctId":"NCT06881264","phase":"PHASE3","title":"A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-04-30","conditions":"Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs","enrollment":401},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT06763328","phase":"PHASE3","title":"Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-12-16","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":200},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT06871761","phase":"PHASE3","title":"A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-05-08","conditions":"Adult Patients With Type 2 Diabetes","enrollment":393},{"nctId":"NCT07307677","phase":"NA","title":"Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-03-11","conditions":"PCOS(Insulin Resistant)","enrollment":60},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT06229795","phase":"PHASE3","title":"Effect of Green Tea on Obese Pediatrics With Prediabetes","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-11-12","conditions":"PreDiabetes","enrollment":90},{"nctId":"NCT06528405","phase":"PHASE2","title":"The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-11-21","conditions":"Acute Kidney Injury","enrollment":264},{"nctId":"NCT06297603","phase":"PHASE3","title":"Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-15","conditions":"Type 2 Diabetes","enrollment":320},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT07272109","phase":"PHASE3","title":"Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-01-01","conditions":"Pancreatic Cancer","enrollment":210},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT03107884","phase":"EARLY_PHASE1","title":"Role of Metformin on Muscle Health of Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Muscle Atrophy, Insulin Resistance","enrollment":64},{"nctId":"NCT04588259","phase":"PHASE3","title":"Research Study to Compare a New Medicine \"Fast-acting Insulin Aspart\" to Another Medicine \"Insulin Aspart\" in Chinese People With Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-10-09","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":331},{"nctId":"NCT06323161","phase":"PHASE3","title":"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-03-26","conditions":"Type 2 Diabetes","enrollment":274},{"nctId":"NCT06688123","phase":"PHASE2","title":"Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-01-08","conditions":"Type 2 Diabetes","enrollment":275},{"nctId":"NCT04578652","phase":"PHASE3","title":"Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2021-10-22","conditions":"Obesity, Childhood, Insulin Resistance","enrollment":90},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT04742751","phase":"PHASE2","title":"An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-03-02","conditions":"PreDiabetes, Adult Children","enrollment":96},{"nctId":"NCT06490874","phase":"","title":"Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2025-09","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":""},{"nctId":"NCT06109311","phase":"PHASE3","title":"A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-11-10","conditions":"Type 2 Diabetes","enrollment":546},{"nctId":"NCT04392284","phase":"NA","title":"Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-04-19","conditions":"Insulin Resistance, Obesity, Diabetes","enrollment":40},{"nctId":"NCT05260021","phase":"PHASE3","title":"A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-04-13","conditions":"Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2","enrollment":99},{"nctId":"NCT01471808","phase":"PHASE4","title":"Effects of Different Early Intensive Therapies on Long-term β-cell Function","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2011-10","conditions":"Diabetes Mellitus, Type 2","enrollment":264},{"nctId":"NCT05413369","phase":"PHASE3","title":"iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2022-07-07","conditions":"Type 2 Diabetes Mellitus","enrollment":582},{"nctId":"NCT03617458","phase":"PHASE2","title":"Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Pulmonary Artery Hypertension","enrollment":73},{"nctId":"NCT07131384","phase":"NA","title":"Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-01","conditions":"Males, Females, Sedentary","enrollment":24},{"nctId":"NCT05932251","phase":"","title":"Towards Precision Medicine for Diabetes in Pregnancy","status":"SUSPENDED","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-06-19","conditions":"Gestational Diabetes, Gestational Diabetes Mellitus","enrollment":103},{"nctId":"NCT07074379","phase":"NA","title":"Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-21","conditions":"Painless Chronic Pancreatitis","enrollment":126},{"nctId":"NCT05098470","phase":"PHASE3","title":"Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-03-07","conditions":"Type 2 Diabetes","enrollment":100},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT05414409","phase":"PHASE2","title":"The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action","status":"RECRUITING","sponsor":"Heba M. Ismail","startDate":"2022-09-30","conditions":"Type 1 Diabetes, Obesity","enrollment":114},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT06846138","phase":"NA","title":"Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study","status":"ENROLLING_BY_INVITATION","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2025-03-01","conditions":"Diabetes Mellitus Type 2","enrollment":66},{"nctId":"NCT07058675","phase":"NA","title":"Myoinositol vs. Metformin for Polycystic Ovarian Syndrome (PCOS): Impact on Metabolic Health and Fertility","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-11-25","conditions":"PCOS","enrollment":156},{"nctId":"NCT07057271","phase":"PHASE3","title":"A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues","status":"COMPLETED","sponsor":"Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.","startDate":"2021-05-27","conditions":"Type 2 Diabetes Mellitus - Poor Control","enrollment":464},{"nctId":"NCT06836128","phase":"PHASE3","title":"The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-03-01","conditions":"Polycystic Ovary Syndrome","enrollment":102},{"nctId":"NCT02500147","phase":"PHASE4","title":"Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)","status":"TERMINATED","sponsor":"Columbia University","startDate":"2011-09-08","conditions":"Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome","enrollment":3},{"nctId":"NCT06924658","phase":"PHASE2","title":"Metformin in Safety and Efficacy in Gouty Patients","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-04-20","conditions":"Gout","enrollment":70},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT06319560","phase":"NA","title":"Hydroxychloroquine in Type 2 Diabetes During Pregnancy","status":"RECRUITING","sponsor":"National University of Malaysia","startDate":"2024-03-24","conditions":"Diabetes in Pregnancy, Type 2 Diabetes","enrollment":56},{"nctId":"NCT05966792","phase":"NA","title":"SGLT2 Inhibitors in Treating Patients With PCOS","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai 10th People's Hospital","startDate":"2023-11-10","conditions":"Polycystic Ovary Syndrome","enrollment":80},{"nctId":"NCT04375657","phase":"PHASE2","title":"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial","status":"RECRUITING","sponsor":"Intervene Immune, Inc.","startDate":"2020-11-23","conditions":"Epigenetic Aging, Immunosenescence","enrollment":85},{"nctId":"NCT05040087","phase":"NA","title":"Changing the Natural History of Type 2 Diabetes (\"CHANGE\" Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Foundation for Atlanta Veterans Education and Research, Inc.","startDate":"2021-09-01","conditions":"Type 2 Diabetes","enrollment":127},{"nctId":"NCT04264897","phase":"PHASE3","title":"Antecedent Metabolic Health and Metformin Aging Study","status":"COMPLETED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2020-07-29","conditions":"Aging, Insulin Sensitivity, Chronic Disease","enrollment":101},{"nctId":"NCT06946628","phase":"PHASE3","title":"New Triple Therapy in Newly Diagnosed Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-06-01","conditions":"Diabetes Mellitus","enrollment":296},{"nctId":"NCT06913881","phase":"","title":"Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2010-01-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":92100},{"nctId":"NCT06107153","phase":"PHASE3","title":"Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control","status":"COMPLETED","sponsor":"University of Basrah","startDate":"2023-11-01","conditions":"Type2diabetes","enrollment":243},{"nctId":"NCT06452511","phase":"EARLY_PHASE1","title":"Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS","status":"COMPLETED","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2024-08-01","conditions":"PCOS","enrollment":100},{"nctId":"NCT04809311","phase":"","title":"Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-04-30","conditions":"Diabetes Mellitus, Type 2","enrollment":156},{"nctId":"NCT06882291","phase":"NA","title":"Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-03-20","conditions":"Polycystic Ovary Syndrome","enrollment":72},{"nctId":"NCT06860841","phase":"PHASE4","title":"Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Campus Bio-Medico University","startDate":"2025-01-10","conditions":"Type 2 Diabetes, Overweight and Obese Adults","enrollment":16},{"nctId":"NCT04409795","phase":"PHASE2, PHASE3","title":"Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study","status":"COMPLETED","sponsor":"Joslin Diabetes Center","startDate":"2021-08-26","conditions":"Type 1 Diabetes, Monogenic Diabetes","enrollment":3},{"nctId":"NCT05306028","phase":"PHASE2","title":"Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fudan University","startDate":"2022-08-01","conditions":"Pancretic Cancer, Diabete Mellitus","enrollment":20},{"nctId":"NCT02695121","phase":"","title":"Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-01-01","conditions":"Breast Cancer, Bladder Cancer","enrollment":2133575},{"nctId":"NCT03960333","phase":"","title":"Immunometabolism in Pediatric Obesity","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2019-04-25","conditions":"Obesity, Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":82},{"nctId":"NCT03323294","phase":"","title":"Bioenergetics and Metabolism in Pediatric Populations","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2017-10-18","conditions":"Obesity, Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":79},{"nctId":"NCT04114136","phase":"PHASE2","title":"Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies","status":"RECRUITING","sponsor":"Dan Zandberg","startDate":"2020-09-14","conditions":"Melanoma, NSCLC, Hepatocellular Carcinoma","enrollment":72},{"nctId":"NCT06473662","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects","status":"COMPLETED","sponsor":"Roger New","startDate":"2018-10-22","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":153},{"nctId":"NCT06806345","phase":"PHASE1, PHASE2","title":"Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-01-28","conditions":"Insulin Resistance Syndrome","enrollment":40},{"nctId":"NCT06528002","phase":"","title":"Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan","status":"COMPLETED","sponsor":"Sohag University","startDate":"2024-03-01","conditions":"Continous Blood Glucose Monitoring, Calculation of Body Mass Index, Measurment of Blood Pressure","enrollment":45},{"nctId":"NCT06781775","phase":"PHASE4","title":"GDM: Insulin with or Without Metformin?","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2024-12-12","conditions":"Gestational Diabetes","enrollment":130},{"nctId":"NCT02515773","phase":"PHASE4","title":"Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs","status":"COMPLETED","sponsor":"Melissa Delbello","startDate":"2015-12","conditions":"Bipolar Disorder","enrollment":1565},{"nctId":"NCT06772857","phase":"EARLY_PHASE1","title":"Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-07-18","conditions":"Insulin Sensitivity/Resistance","enrollment":3},{"nctId":"NCT06125587","phase":"PHASE2, PHASE3","title":"Chiglitazar/Metformin in Non-obese Women With PCOS","status":"COMPLETED","sponsor":"Shengjing Hospital","startDate":"2023-11-15","conditions":"Polycystic Ovary Syndrome, Chiglitazar, Metformin","enrollment":55},{"nctId":"NCT03029702","phase":"PHASE4","title":"Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Maisa N. Feghali, MD","startDate":"2018-02-28","conditions":"Gestational Diabetes, Diabetes, Gestational, Pregnancy in Diabetes","enrollment":54},{"nctId":"NCT06691542","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-11-14","conditions":"Non-Genital Warts","enrollment":108},{"nctId":"NCT04836910","phase":"","title":"Microbiome and Polycystic Ovaries","status":"NOT_YET_RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-01","conditions":"Polycystic Ovary Syndrome, Microbial Colonization","enrollment":40},{"nctId":"NCT06675994","phase":"","title":"In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme","status":"NOT_YET_RECRUITING","sponsor":"LifeBridge Health","startDate":"2024-12-01","conditions":"Healthy, Hypercholesterolemia, Hypertension","enrollment":80},{"nctId":"NCT03558867","phase":"NA","title":"Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes","status":"COMPLETED","sponsor":"Garvan Institute of Medical Research","startDate":"2018-06-05","conditions":"Pre Diabetes, Type 2 Diabetes Mellitus","enrollment":138},{"nctId":"NCT05275608","phase":"NA","title":"Effects of VLCKD in Metabolic Syndrome","status":"RECRUITING","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2022-11-07","conditions":"Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Obesity","enrollment":40},{"nctId":"NCT06613854","phase":"PHASE4","title":"Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":90},{"nctId":"NCT02647827","phase":"PHASE2","title":"Acupuncture or Metformin for Insulin Resistance in Women With PCOS","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2015-12","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Hyperandrogenism","enrollment":303},{"nctId":"NCT04017221","phase":"","title":"Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients with Type 2 Diabetes","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 2, Urosepsis, Diabetic Ketoacidosis","enrollment":1249636},{"nctId":"NCT01107717","phase":"PHASE4","title":"Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2009-01","conditions":"Diabetes","enrollment":318},{"nctId":"NCT02431676","phase":"PHASE2","title":"Survivorship Promotion In Reducing IGF-1 Trial","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2015-05","conditions":"Breast Cancer, Prostate Cancer, Lung Cancer","enrollment":121},{"nctId":"NCT06559722","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Tonghua Dongbao Pharmaceutical Co.,Ltd","startDate":"2024-08","conditions":"Type 2 Diabetes","enrollment":510},{"nctId":"NCT06545994","phase":"","title":"A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-06-28","conditions":"Polycystic Ovary Syndrome, Pregnancy Complications","enrollment":180}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BRUXISM"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"FEELING COLD"},{"count":1,"reaction":"REFUSAL OF TREATMENT BY PATIENT"},{"count":1,"reaction":"TREMOR"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metformin and insulin","genericName":"Metformin and insulin","companyName":"Takeda","companyId":"takeda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while insulin directly replaces or supplements endogenous insulin to lower blood glucose. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}